top of page

Somatuline Autogel Prolonged Release Solution for Injection in a Pre-filled Syringe 60 mg

Product details

Registration number: SIN14291P

Classification: Prescription Only

Active ingredients: Lanreotide Acetate 77.9mg eqv lanreotide

Strength: 60 mg

Dosage form: INJECTION, SOLUTION

Route: SUBCUTANEOUS

Registrant: IPSEN PHARMA SINGAPORE PTE. LTD.

ATC code: H01C B03

HSA approval date: 16 January 2013

Manufacturer(s):

  • Ipsen Pharma Biotech
  • IPSEN PHARMA BIOTECH, ETABLISSEMENT GAMMASTER - Gamma Irradiation
  • STERIGENICS BELGIUM - Gamma Irradiation

Manufacturing country/countries: FRANCE; BELGIUM

What are the HSA registration number and classification for Somatuline Autogel Prolonged Release Solution for Injection in a Pre-filled Syringe 60 mg?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN14291P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for Somatuline Autogel Prolonged Release Solution for Injection in a Pre-filled Syringe 60 mg?

According to the HSA dataset updated 7 August 2026:

Active ingredients: Lanreotide Acetate 77.9mg eqv lanreotide

Strength: 60 mg

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for Somatuline Autogel Prolonged Release Solution for Injection in a Pre-filled Syringe 60 mg?

According to the HSA dataset updated 7 August 2026:

Dosage form: INJECTION, SOLUTION

Route: SUBCUTANEOUS

Source for this answer

Who is the recorded registrant for Somatuline Autogel Prolonged Release Solution for Injection in a Pre-filled Syringe 60 mg?

According to the HSA dataset updated 7 August 2026:

Registrant: IPSEN PHARMA SINGAPORE PTE. LTD.

Source for this answer

Which manufacturers and countries are listed for Somatuline Autogel Prolonged Release Solution for Injection in a Pre-filled Syringe 60 mg?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s):

  • Ipsen Pharma Biotech
  • IPSEN PHARMA BIOTECH, ETABLISSEMENT GAMMASTER - Gamma Irradiation
  • STERIGENICS BELGIUM - Gamma Irradiation

Manufacturing country/countries: FRANCE; BELGIUM

Source for this answer

Where can I look up Somatuline Autogel Prolonged Release Solution for Injection in a Pre-filled Syringe 60 mg in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN14291P or the exact product name Somatuline Autogel Prolonged Release Solution for Injection in a Pre-filled Syringe 60 mg. The general register link does not preselect this product.

Source for this answer

What are the source dates for this Somatuline Autogel Prolonged Release Solution for Injection in a Pre-filled Syringe 60 mg record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this Somatuline Autogel Prolonged Release Solution for Injection in a Pre-filled Syringe 60 mg record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN14291P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page